NCT05069350View on ClinicalTrials.gov

Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Pain, Acute
Interventions
DRUG

bupivacaine 0.5% and oxubuprocaine

using each drug as surface anesthesia before intravitreal injections

Trial Locations (1)

12513

Research Institute of Ophthamology, Giza

All Listed Sponsors
lead

Research Institute of Ophthalmology, Egypt

OTHER

NCT05069350 - Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI | Biotech Hunter | Biotech Hunter